MicroTech Medical Hangzhou Co Ltd
HKEX:2235

Watchlist Manager
MicroTech Medical Hangzhou Co Ltd Logo
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Watchlist
Price: 4.5 HKD 1.81% Market Closed
Market Cap: 1.9B HKD
Have any thoughts about
MicroTech Medical Hangzhou Co Ltd?
Write Note

MicroTech Medical Hangzhou Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MicroTech Medical Hangzhou Co Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Cash from Operating Activities
-ÂĄ107.7m
CAGR 3-Years
-124%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cash from Operating Activities
ÂĄ689.1m
CAGR 3-Years
67%
CAGR 5-Years
106%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash from Operating Activities
ÂĄ1.8B
CAGR 3-Years
9%
CAGR 5-Years
26%
CAGR 10-Years
28%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash from Operating Activities
ÂĄ15.1B
CAGR 3-Years
23%
CAGR 5-Years
27%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Cash from Operating Activities
ÂĄ1.2B
CAGR 3-Years
3%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash from Operating Activities
ÂĄ132.5m
CAGR 3-Years
-66%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

MicroTech Medical Hangzhou Co Ltd
Glance View

Market Cap
1.9B HKD
Industry
Health Care

MicroTech Medical (Hangzhou) Co., Ltd. engages in the research, development, manufacture, and sale of diabetes management medical devices. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-10-19. The firm's products such as applicator insulin pump system (Equil), blood glucose monitoring system and continuous blood glucose monitoring system (AiDEX G7) have been commercialized. The firm's products, such as artificial pancreas, are in the process of research and development. The firm's products are sold to overseas markets such as the United States and the European Union.

Intrinsic Value
5.87 HKD
Undervaluation 23%
Intrinsic Value
Price

See Also

What is MicroTech Medical Hangzhou Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
-107.7m CNY

Based on the financial report for Dec 31, 2023, MicroTech Medical Hangzhou Co Ltd's Cash from Operating Activities amounts to -107.7m CNY.

What is MicroTech Medical Hangzhou Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-124%

Over the last year, the Cash from Operating Activities growth was 0%. The average annual Cash from Operating Activities growth rates for MicroTech Medical Hangzhou Co Ltd have been -124% over the past three years .

Back to Top